As a result, inhibiting the PI3K/Akt/mTOR pathway is considered a potentially attractive treatment for cancer cells [61] as reported when the following compounds were isolated: tanshinone I (from Salvia miltiorrhiza) [63], lanatoside C [22], isoorientin [55], mahanine [18], piperlongumine [24], and apigetrin [64]. The gene discussed is MTOR; the disease is cancer.